Search
Cancer Types
Immunotherapy for Ovarian Cancer
… infused back into the patient. Become a patient Dr. Emese Zsiros explains some of the current clinical trials at …
Research
Roswell Park-University of Chicago Ovarian Cancer SPORE Clinical Trials
Page with Layout
Faculty Mentors
… Sai Yendamuri, MD, MBA, FACS Thoracic Surgery Emese Zsiros, MD, PhD, FACOG Gynecologic Oncology Oncology …
Blog Post
Does your gut biome affect your response to immunotherapy?
… The study was led by Principal Investigator Emese Zsiros, MD, PhD, FACOG , Chair of Gynecologic Oncology. All … the biological mechanisms behind them,” says Dr. Zsiros. “We observed that patients who experienced a … conditions. In the more immediate future, Drs. Zsiros and Rosario are exploring Dielma fastidiosa, a …
News
Roswell Park Community Comes Together to Celebrate Outstanding Physicians
… a robotic approach to pancreaticoduodenectomy.” Emese Zsiros, MD, PhD, FACOG — Breaking Barriers Award for Visionary Leadership Dr. Zsiros, Chair of Gynecologic Oncology and the Shashi Lele, … status quo, and leads with clarity and courage. “Dr. Emese Zsiros has a rare and remarkable ability to transform vision …
Clinical Trial
Randomized Phase 2 Clinical Trial of Pembrolizumab Combined with Bevacizumab with or without Agonist Anti-CD40 CDX-1140 in Patients with Recurrent Ovarian Cancer
… CDX-1140 in Patients with Recurrent Ovarian Cancer II Zsiros, Emese This phase II trial tests whether pembrolizumab …
Department of Immunology Faculty
… Professor of Oncology Department of Immunology Emese Zsiros, MD, PhD, FACOG Professor of Oncology Co-Leader, Tumor …
Blog Post
Coping with hair loss: Jerrolynn's story
… oncologists Katherine LaVigne Mager, MD, FACOG and Emese Zsiros, MD, PhD, FACOG. “Dr. Mager is a godsend and Dr. Zsiros was my first doctor here and integral in discovering … oncologists Katherine LaVigne Mager, MD, FACOG and Emese Zsiros, MD, PhD, FACOG. “Dr. Mager is a godsend and Dr. …
Clinical Trial
Randomized Phase 2 Trial of APL-2 with Pembrolizumab vs. APL-2 with Pembrolizumab and Bevacizumab vs. Bevacizumab alone in Patients with Recurrent Ovarian Cancer and Persistent Malignant Effusion
… Ovarian Cancer and Persistent Malignant Effusion II Zsiros, Emese This phase II trial studies the effect of APL-2 …
Tumor Immunology & Immunotherapy Program Members
… Chair, Department of Immunology View the Abrams Lab Emese Zsiros, MD, PhD, FACOG Professor of Oncology Co-Leader, Tumor …